These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2062627)

  • 21. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y; Granoff DM
    JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
    Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
    [No Abstract]   [Full Text] [Related]  

  • 23. Antigenuria after Haemophilus influenzae type b polysaccharide immunization: a prospective study.
    Spinola SM; Sheaffer CI; Philbrick KB; Gilligan PH
    J Pediatr; 1986 Nov; 109(5):835-8. PubMed ID: 3490560
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.
    Booy R; Heath PT; Slack MP; Begg N; Moxon ER
    Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants.
    Capeding MR; Nohynek H; Pascual LG; Kayhty H; Sombrero LT; Eskola J; Ruutu P
    Am J Trop Med Hyg; 1996 Nov; 55(5):516-20. PubMed ID: 8940983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemophilus influenzae type B conjugate vaccines.
    Kaplan SL
    Pediatr Ann; 1990 Dec; 19(12):712-3, 716-8. PubMed ID: 2280990
    [No Abstract]   [Full Text] [Related]  

  • 29. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines.
    Englund JA; Glezen WP; Turner C; Harvey J; Thompson C; Siber GR
    J Infect Dis; 1995 Jan; 171(1):99-105. PubMed ID: 7798688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age.
    Hay JW; Daum RS
    Pediatr Infect Dis J; 1990 Apr; 9(4):246-52. PubMed ID: 2110651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
    Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
    Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines.
    Carlsson RM; Claesson BA; Iwarson S; Lagergård T; Käyhty H
    Pediatr Infect Dis J; 1994 Jan; 13(1):27-33. PubMed ID: 8170729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
    Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
    JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children.
    CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591
    [No Abstract]   [Full Text] [Related]  

  • 35. Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria-tetanus-whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib.
    Araújo OO; Forleo-Neto E; Vespa GN; Puccini RF; Weckx LW; Carvalho ES; Farhat CK
    Vaccine; 2000 Sep; 19(2-3):367-75. PubMed ID: 10930692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine. Recommendations of the advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1993 Sep; 42(RR-13):1-15. PubMed ID: 8145705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with sickle cell disease.
    Rubin LG; Voulalas D; Carmody L
    Am J Dis Child; 1992 Mar; 146(3):340-2. PubMed ID: 1543182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
    Gordon LK
    Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New considerations for Haemophilus influenzae type b vaccination.
    Pinson JB; Weart CW
    Clin Pharm; 1992 Apr; 11(4):332-6. PubMed ID: 1563228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP).
    MMWR Recomm Rep; 1991 Jan; 40(RR-1):1-7. PubMed ID: 1899280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.